The Real Cause of a Common Stroke May Have Been Missed for Decades

New Delhi, India Jul 3, 2026 ALN: Scientists have uncovered evidence that could change how doctors think about a common form of stroke and why standard preventive treatments often fail. This revelation comes at a critical time when stroke remains one of the leading causes of death and disability worldwide, affecting millions of individuals and imposing a significant burden on care systems.

New research suggests that lacunar ischemic stroke is not primarily caused by fatty plaque building up inside arteries, as many have assumed. Instead, the strongest link appears to be with changes in the brain's blood vessels themselves, specifically the enlargement and widening of arteries. This shift in understanding could lead to more effective treatments and preventive measures for this type of stroke, which is often overlooked in discussions about stroke risk.

The findings may help explain why commonly prescribed stroke prevention medications such as aspirin and other antiplatelet drugs have had limited success in preventing this type of stroke. Lacunar strokes, which account for approximately 25% of all ischemic strokes, are particularly insidious because they often occur without obvious symptoms, leading many patients to be unaware of their risk until it is too late.

Researchers say the results are already helping guide new treatment strategies, including the LACunar Intervention Trial 3 (LACI-3), which is evaluating drugs designed to protect and support the brain's smallest blood vessels. This trial represents a significant step forward in stroke research, as it addresses the need for targeted therapies that focus on the underlying mechanisms of lacunar strokes rather than merely managing symptoms.

Brain Small Vessel Disease and Stroke Risk

Lacunar stroke develops when the brain's tiniest blood vessels are damaged by a condition known as small vessel disease. This form of stroke is a major cause of disability and is linked to cognitive decline, dementia, and an increased risk of future strokes. Despite its importance, scientists have struggled to pinpoint exactly what drives the disease, making it difficult to develop effective treatments. The implications of small vessel disease extend beyond individual , as it contributes to broader public challenges, including the rising prevalence of dementia in aging populations.

To investigate, researchers from the University of Edinburgh, the UK Dementia Research Institute, and international collaborators examined 229 people who had experienced either a lacunar stroke or a mild non-lacunar stroke. This diverse cohort allowed researchers to draw comparisons and gain insights into the different mechanisms at play in various stroke types.

Participants received clinical and cognitive evaluations and underwent MRI brain scans shortly after their stroke and again one year later. The imaging allowed scientists to assess stroke type, monitor signs of small vessel disease, and identify any new areas of brain injury that developed over time. This longitudinal approach is crucial for understanding the progression of small vessel disease and its impact on brain .

The team compared two different vascular changes: fatty narrowing of larger arteries and the widening and elongation of arteries within the brain. The results of this analysis were striking and have significant implications for future research and treatment approaches.

Artery Widening Emerges as a Key Clue

The analysis showed that narrowing of large arteries was not associated with lacunar stroke or with small vessel disease. While artery narrowing was more common in other forms of stroke, it did not predict new brain damage on follow-up scans. This finding challenges long-held assumptions about the primary causes of strokes and emphasizes the need for a paradigm shift in stroke research and treatment.

In contrast, artery widening showed a strong connection to lacunar stroke. Patients with enlarged arteries were more than four times more likely to have experienced a lacunar stroke. This correlation suggests that interventions aimed at preventing or reversing artery widening could be key to reducing the incidence of lacunar strokes.

Researchers also found that artery widening was linked to more severe small vessel disease, faster progression of brain damage, and a greater likelihood of developing new 'silent' strokes—small areas of brain tissue damage caused by interrupted blood supply that can occur without obvious symptoms. More than one in four participants developed these silent strokes during the study, even though they were receiving standard treatments intended to prevent additional strokes. This statistic highlights the inadequacy of current treatment approaches and the urgent need for new strategies that address the root causes of lacunar strokes.

New Treatment Approaches Being Tested

The findings suggest that future therapies should focus on the underlying damage affecting the brain's small blood vessels rather than on fatty plaque in larger arteries. This shift in focus could lead to more effective prevention strategies and treatments that not only reduce the risk of stroke but also improve cognitive outcomes for patients.

Studies such as LACI-3 are currently investigating whether existing medications, including cilostazol and isosorbide mononitrate, can help protect the brain, lower the risk of additional strokes, and reduce long-term problems involving memory, mobility, and dementia following lacunar stroke. These medications, which have shown promise in other vascular conditions, may offer new hope for patients suffering from the effects of small vessel disease.

Joanna Wardlaw, Professor of Applied Neuroimaging at the University of Edinburgh's Institute for Neuroscience and Cardiovascular Disease and Group Leader at the UK Dementia Research Institute, emphasized the importance of this research. She stated,

"This study provides strong evidence that lacunar stroke is not caused by fatty blockage of larger arteries, but by disease of the small vessels within the brain itself. Recognising this distinction is crucial, because it explains why conventional treatments like antiplatelet drugs are not as effective for this type of stroke and highlights the urgent need to develop new therapies that target the underlying microvascular damage."

The study was published in the journal Circulation, a leading publication in cardiovascular . Funding was provided by the UK Dementia Research Institute (funded by the UK Medical Research Council, Alzheimer's Society and Alzheimer's Research UK), the Leducq Foundation, the Stroke Association, British Heart Foundation, Scottish Government's Chief Scientist Office, Row Fogo Charitable Trust, Wellcome Trust, and other national funding agencies. The research team also included scientists from China and Mexico, demonstrating the global nature of this critical research effort.

As the medical community continues to grapple with the implications of these findings, there is hope that a deeper understanding of lacunar strokes will lead to improved outcomes for patients and a reduction in the overall burden of stroke-related disability. The need for ongoing research into the mechanisms of small vessel disease and its impact on brain cannot be overstated, as it is essential for developing effective interventions that can significantly alter the trajectory of this common yet often misunderstood condition.